In the correlation analysis, ZBTB42 is positively related to the expression of CSF-1 in both LGG and GBM indicating ZBTB42 is associated with immune suppression in glioma and this feature may be related to the increased expression of CSF-1. This evidence concerns the gene ZBTB42 and central nervous system cancer.